{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:09:08Z","timestamp":1770466148921,"version":"3.49.0"},"reference-count":89,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15405","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:26:27Z","timestamp":1764163587000},"page":"1-13","source":"Crossref","is-referenced-by-count":0,"title":["Small intestinal SMARCA4\u2011deficient undifferentiated carcinoma with intussusception: A case report"],"prefix":"10.3892","volume":"31","author":[{"given":"Xiaoshan","family":"Cai","sequence":"first","affiliation":[{"name":"Department of Pathology, Weifang No. 2 People's Hospital, Weifang Respiratory Disease Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiac Critical Care and Rehabilitation, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linqian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology, Weifang No. 2 People's Hospital, Weifang Respiratory Disease Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Weifang No. 2 People's Hospital, Weifang Respiratory Disease Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weifang No. 2 People's Hospital, Weifang Respiratory Disease Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weifang No. 2 People's Hospital, Weifang Respiratory Disease Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihua","family":"Qu","sequence":"additional","affiliation":[{"name":"Translational Medical Center, Weifang No. 2 People's Hospital, Weifang Respiratory Disease Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubing","family":"Wang","sequence":"additional","affiliation":[{"name":"Translational Medical Center, Weifang No. 2 People's Hospital, Weifang Respiratory Disease Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Yang","sequence":"additional","affiliation":[{"name":"Translational Medical Center, Weifang No. 2 People's Hospital, Weifang Respiratory Disease Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianwen","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Radiology, Weifang No. 2 People's Hospital, Weifang Respiratory Disease Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"key20260206094801_b1-ol-31-2-15405","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20260206094801_b2-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global burden of 5 major types of gastrointestinal cancer","volume":"159","author":"Arnold","year":"2020","journal-title":"Gastroenterology"},{"key":"key20260206094801_b3-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41392-024-02097-4","article-title":"Digestive cancers: Mechanisms, therapeutics and management","volume":"10","author":"Zhan","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"key20260206094801_b4-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"key20260206094801_b5-ol-31-2-15405","first-page":"868","article-title":"SMARCA4-deficient undifferentiated carcinoma of the gastrointestinal tract: a clinicopathological and immunohistochemical study of nine cases","volume":"51","author":"Zhu","year":"2022","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"key20260206094801_b6-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"216022","DOI":"10.1016\/j.canlet.2022.216022","article-title":"SMARCA4: Current status and future perspectives in non-small-cell lung cancer","volume":"554","author":"Tian","year":"2023","journal-title":"Cancer Lett"},{"key":"key20260206094801_b7-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"e41128","DOI":"10.1016\/j.heliyon.2024.e41128","article-title":"The impact of SMARCA4 loss in non-small cell lung cancer therapy","volume":"11","author":"Lombardi","year":"2024","journal-title":"Heliyon"},{"key":"key20260206094801_b8-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"107818","DOI":"10.1016\/j.lungcan.2024.107818","article-title":"Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods","volume":"192","author":"Shi","year":"2024","journal-title":"Lung Cancer"},{"key":"key20260206094801_b9-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1038\/s41467-021-25260-9","article-title":"SMARCA4\/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria","volume":"12","author":"Xue","year":"2021","journal-title":"Nat Commun"},{"key":"key20260206094801_b10-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/cancers13215474","article-title":"SMARCA4 depletion induces cisplatin resistance by activating YAP1-mediated epithelial-to-mesenchymal transition in triple-negative breast cancer","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20260206094801_b11-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"key20260206094801_b12-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.dld.2017.09.123","article-title":"Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)","volume":"50","author":"Locher","year":"2018","journal-title":"Dig Liver Dis"},{"key":"key20260206094801_b13-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"e006658","DOI":"10.1136\/jitc-2022-006658","article-title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer","volume":"11","author":"Kelly","year":"2023","journal-title":"J Immunother Cancer"},{"key":"key20260206094801_b14-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"108022","DOI":"10.1016\/j.lungcan.2024.108022","article-title":"Effective treatment strategies and key factors influencing therapeutic efficacy in advanced SMARCA4-deficient non-small cell lung cancer","volume":"198","author":"Liu","year":"2024","journal-title":"Lung Cancer"},{"key":"key20260206094801_b15-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","article-title":"The genome sequence archive family: Toward explosive data growth and diverse data types","volume":"19","author":"Chen","year":"2021","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"D1","key":"key20260206094801_b16-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"D27","DOI":"10.1093\/nar\/gkab951","article-title":"Database resources of the national genomics data center, china national center for bioinformation in 2022","volume":"50","author":"CNCB-NGDC Members and Partners","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"key20260206094801_b17-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1158\/2159-8290.CD-16-0512","article-title":"A First-in-human phase I study of the ATP-competitive AKT inhibitor ipatasertib demonstrates robust and safe targeting of AKT in patients with solid tumors","volume":"7","author":"Saura","year":"2017","journal-title":"Cancer Discov"},{"key":"key20260206094801_b18-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3109\/0284186X.2014.895036","article-title":"The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis","volume":"53","author":"Therkildsen","year":"2014","journal-title":"Acta Oncol"},{"key":"key20260206094801_b19-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00280-012-1886-y","article-title":"Loss of PTEN expression as a predictor of resistance to anti-EGFR monoclonal therapy in metastatic colorectal cancer: Evidence from retrospective studies","volume":"69","author":"Wang","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20260206094801_b20-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrclinonc.2011.42","article-title":"Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer","volume":"8","author":"Forster","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"key20260206094801_b21-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/annonc\/mdv598","article-title":"TP53 mutational status is predictive of pazopanib response in advanced sarcomas","volume":"27","author":"Koehler","year":"2016","journal-title":"Ann Oncol"},{"key":"key20260206094801_b22-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","article-title":"PTEN and the PI3-kinase pathway in cancer","volume":"4","author":"Chalhoub","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"key20260206094801_b23-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fonc.2015.00024","article-title":"PTEN: Multiple functions in human malignant tumors","volume":"5","author":"Milella","year":"2015","journal-title":"Front Oncol"},{"key":"key20260206094801_b24-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1517\/14728222.2011.648617","article-title":"Targeting the EGFR signaling pathway in cancer therapy","volume":"16","author":"Seshacharyulu","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"key20260206094801_b25-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.12155","article-title":"Emerging functions of the EGFR in cancer","volume":"12","author":"Sigismund","year":"2018","journal-title":"Mol Oncol"},{"key":"key20260206094801_b26-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1200\/JCO.2011.36.1360","article-title":"Phase I, dose-escalation study of BKM120, an oral pan-class I PI3K inhibitor, in patients with advanced solid tumors","volume":"30","author":"Bendell","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20260206094801_b27-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2165\/0063030-200822060-00006","article-title":"Panitumumab: In metastatic colorectal cancer with wild-type KRAS","volume":"22","author":"Weber","year":"2008","journal-title":"BioDrugs"},{"key":"key20260206094801_b28-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"e81224","DOI":"10.7554\/eLife.81224","article-title":"Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns","volume":"12","author":"S\u00f8rensen","year":"2023","journal-title":"Elife"},{"key":"key20260206094801_b29-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12920-024-01965-w","article-title":"Genomic landscape of hepatocellular carcinoma in Egyptian patients by whole exome sequencing","volume":"17","author":"Kassem","year":"2024","journal-title":"BMC Med Genomics"},{"key":"key20260206094801_b30-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/sj.bjc.6606018","article-title":"Regulation of PTEN expression by the SWI\/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells","volume":"104","author":"Watanabe","year":"2011","journal-title":"Br J Cancer"},{"key":"key20260206094801_b31-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.annonc.2023.12.007","article-title":"Liquid biopsy response evaluation criteria in solid tumors (LB-RECIST)","volume":"35","author":"Gouda","year":"2024","journal-title":"Ann Oncol"},{"key":"key20260206094801_b32-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"e0226084","DOI":"10.1371\/journal.pone.0226084","article-title":"Meta-analysis of the radiological and clinical features of usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP)","volume":"15","author":"Ebner","year":"2020","journal-title":"PLoS One"},{"key":"key20260206094801_b33-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41698-023-00367-y","article-title":"The SMARCA4R1157W mutation facilitates chromatin remodeling and confers PRMT1\/SMARCA4 inhibitors sensitivity in colorectal cancer","volume":"7","author":"Zeng","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"key20260206094801_b34-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"14171","DOI":"10.1002\/cam4.6083","article-title":"Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer","volume":"12","author":"Liang","year":"2023","journal-title":"Cancer Med"},{"key":"key20260206094801_b35-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1136\/jmg-2022-108854","article-title":"Germline pathogenic SMARCA4 variants in neuroblastoma","volume":"60","author":"Witkowski","year":"2023","journal-title":"J Med Genet"},{"key":"key20260206094801_b36-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"100183","DOI":"10.1016\/j.modpat.2023.100183","article-title":"SMARCA4 mutations in carcinomas of the esophagus, esophagogastric junction, and stomach","volume":"36","author":"Neil","year":"2023","journal-title":"Mod Pathol"},{"key":"key20260206094801_b37-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/his.14636","article-title":"Primary uterine synovial sarcoma with SMARCA4 loss","volume":"80","author":"Pors","year":"2022","journal-title":"Histopathology"},{"key":"key20260206094801_b38-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/RLU.0000000000005217","article-title":"SMARCA4-deficient poorly differentiated adenocarcinoma of the gallbladder","volume":"49","author":"Koyasu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"key20260206094801_b39-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1038\/cddis.2012.93","article-title":"Non-small cell lung cancer stem\/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity","volume":"3","author":"Akunuru","year":"2012","journal-title":"Cell Death Dis"},{"key":"key20260206094801_b40-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/tgh-23-84","article-title":"Esophageal carcinoma with SMARCA4 mutation: A narrative review for this rare entity","volume":"9","author":"Xu","year":"2024","journal-title":"Transl Gastroenterol Hepatol"},{"key":"key20260206094801_b41-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/PAS.0000000000001836","article-title":"SWI\/SNF complex-deficient undifferentiated carcinoma of the gastrointestinal tract: Clinicopathologic study of 30 cases with an emphasis on variable morphology, immune features, and the prognostic significance of different SMARCA4 and SMARCA2 subunit deficiencies","volume":"46","author":"Chang","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"key20260206094801_b42-ol-31-2-15405","article-title":"SMARCA4 mutation induces tumor cell-intrinsic defects in enhancer landscape and resistance to immunotherapy","author":"Wang","year":"2024","journal-title":"bioRxiv"},{"key":"key20260206094801_b43-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"456","DOI":"10.5306\/wjco.v15.i3.456","article-title":"PD-1 antibody in combination with chemotherapy for the treatment of SMARCA4-deficient advanced undifferentiated carcinoma of the duodenum: Two case reports","volume":"15","author":"Shi","year":"2024","journal-title":"World J Clin Oncol"},{"key":"key20260206094801_b44-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-20-1825","article-title":"The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin Cancer"},{"key":"key20260206094801_b45-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/PAS.0000000000000554","article-title":"SWI\/SNF complex-deficient undifferentiated\/rhabdoid carcinomas of the gastrointestinal tract: A series of 13 cases highlighting mutually exclusive loss of SMARCA4 and SMARCA2 and frequent co-inactivation of SMARCB1 and SMARCA2","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"key20260206094801_b46-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"200432","DOI":"10.1016\/j.ehpc.2020.200432","article-title":"Primary SMARCA4-deficient undifferentiated sarcomatoid tumor of the gastroesophageal junction","volume":"22","author":"Liu","year":"2020","journal-title":"Hum Pathol Case Rep"},{"key":"key20260206094801_b47-ol-31-2-15405","first-page":"6171","article-title":"BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines","volume":"60","author":"Wong","year":"2000","journal-title":"Cancer Res"},{"key":"key20260206094801_b48-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1272\/jnms.JNMS.2022_89-501","article-title":"A rapidly growing small-intestinal metastasis from lung cancer","volume":"89","author":"Ankoh","year":"2022","journal-title":"J Nippon Med Sch"},{"key":"key20260206094801_b49-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/diagnostics13030376","article-title":"Gastrointestinal stromal tumour with liver metastasis presenting as gastric cancer","volume":"13","author":"Xu","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"key20260206094801_b50-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s10151-016-1526-3","article-title":"Splenic metastasis in colorectal cancer","volume":"20","author":"Altaf","year":"2016","journal-title":"Tech Coloproctol"},{"key":"key20260206094801_b51-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41417-024-00732-4","article-title":"The golden key to open mystery boxes of SMARCA4-deficient undifferentiated thoracic tumor: Focusing immunotherapy, tumor microenvironment and epigenetic regulation","volume":"31","author":"Li","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"key20260206094801_b52-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.5858\/arpa.2021-0001-OA","article-title":"SMARCA4\/BRG1-deficient sinonasal carcinoma","volume":"146","author":"Kakkar","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"key20260206094801_b53-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5858\/arpa.2019-0633-OA","article-title":"SMARCA4\/BRG1-deficient non-small cell lung carcinomas: A case series and review of the literature","volume":"145","author":"Nambirajan","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"key20260206094801_b54-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"1290717","DOI":"10.3389\/fonc.2023.1290717","article-title":"Case report: Gastrointestinal neuroendocrine carcinoma with SMARCA4 deficiency: A clinicopathological report of two rare cases","volume":"13","author":"Zhou","year":"2023","journal-title":"Front Oncol"},{"key":"key20260206094801_b55-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"262","DOI":"10.31083\/j.fbl2907262","article-title":"SMARCA2 and SMARCA4 participate in DNA damage repair","volume":"29","author":"Yu","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"key20260206094801_b56-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/his.15076","article-title":"Pulmonary squamous cell carcinoma and lymphoepithelial carcinoma-morphology, molecular characteristics and differential diagnosis","volume":"84","author":"Berezowska","year":"2024","journal-title":"Histopathology"},{"key":"key20260206094801_b57-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4132\/jptm.2018.08.14","article-title":"p40 immunohistochemistry is an excellent marker in primary lung squamous cell carcinoma","volume":"52","author":"Affandi","year":"2018","journal-title":"J Pathol Transl Med"},{"key":"key20260206094801_b58-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00428-024-03838-0","article-title":"\u2018Aberrant\u2019 expression of skeletal muscle markers in neuroendocrine carcinomas: A significant diagnostic pitfall","volume":"485","author":"Garcia-Porrero","year":"2024","journal-title":"Virchows Arch"},{"key":"key20260206094801_b59-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/his.15058","article-title":"Updates on lung neuroendocrine neoplasm classification","volume":"84","author":"Vocino Trucco","year":"2024","journal-title":"Histopathology"},{"key":"key20260206094801_b60-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"e256427","DOI":"10.1136\/bcr-2023-256427","article-title":"Melanoma with rhabdomyosarcomatous features: A potential diagnostic pitfall","volume":"16","author":"Watter","year":"2023","journal-title":"BMJ Case Rep"},{"key":"key20260206094801_b61-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/DAD.0000000000001236","article-title":"Undifferentiated sarcoma as intermediate step in the progression of malignant melanoma to rhabdomyosarcoma: Histologic, histologic, immunohistochemical, and molecular studies of a new case of malignant melanoma with rhabdomyosarcomatous differentiation","volume":"41","author":"Tran","year":"2019","journal-title":"Am J Dermatopathol"},{"key":"key20260206094801_b62-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1177\/0300985820988146","article-title":"Evaluation of myogenin and MyoD1 as immunohistochemical markers of canine rhabdomyosarcoma","volume":"58","author":"Tuohy","year":"2021","journal-title":"Vet Pathol"},{"key":"key20260206094801_b63-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.urology.2019.11.050","article-title":"Chemoradiotherapy-induced cytodifferentiation in bladder\/prostate rhabdomyosarcoma with genetic downregulation of myogenin and MyoD1 gene expression: A case study and review of the literature","volume":"137","author":"Agard","year":"2020","journal-title":"Urology"},{"key":"key20260206094801_b64-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.4103\/jcrt.JCRT_955_19","article-title":"Primary gastrointestinal anaplastic large cell lymphoma: A critical reappraisal with a systematic review of the world literature","volume":"17","author":"Mishra","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"key20260206094801_b65-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4103\/IJPM.IJPM_225_19","article-title":"Primary anaplastic large cell lymphoma of caecum and ascending colon","volume":"64","author":"Radha","year":"2021","journal-title":"Indian J Pathol Microbiol"},{"key":"key20260206094801_b66-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/modpathol.3880368","article-title":"Proximal-type epithelioid sarcoma: A clinicopathologic study of 20 cases","volume":"14","author":"Hasegawa","year":"2001","journal-title":"Mod Pathol"},{"key":"key20260206094801_b67-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"238","DOI":"10.11604\/pamj.2016.24.238.8535","article-title":"Proximal-type epithelioid sarcoma: A new case report and literature review","volume":"24","author":"Echchaoui","year":"2016","journal-title":"Pan Afr Med J"},{"key":"key20260206094801_b68-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"S102878","DOI":"10.1016\/j.esmoop.2024.102878","article-title":"228P SMARCA4 inactivation drives aggressiveness in STK11\/KEAP1 co-mutant lung adenocarcinomas through the induction of TGF\u03b2 signaling","volume":"9","author":"Quintanal-Villalonga","year":"2024","journal-title":"ESMO Open"},{"key":"key20260206094801_b69-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s10120-024-01510-9","article-title":"SMARCA4-deficient undifferentiated gastric carcinoma: A case series and literature review","volume":"27","author":"An","year":"2024","journal-title":"Gastric Cancer"},{"key":"key20260206094801_b70-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrc3068","article-title":"SWI\/SNF nucleosome remodellers and cancer","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key20260206094801_b71-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/1878-0261.12831","article-title":"SMARCA4 mutations in KRAS-mutant lung adenocarcinoma: A multi-cohort analysis","volume":"15","author":"Liu","year":"2021","journal-title":"Mol Oncol"},{"key":"key20260206094801_b72-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.jtho.2021.03.024","article-title":"SMARCA4 and other SWItch\/sucrose nonfermentable family genomic alterations in NSCLC: Clinicopathologic characteristics and outcomes to immune checkpoint inhibition","volume":"16","author":"Alessi","year":"2021","journal-title":"J Thorac Oncol"},{"key":"key20260206094801_b73-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"154692","DOI":"10.1016\/j.prp.2023.154692","article-title":"Esophageal carcinoma with SMARCA4 mutation: Unique diagnostic challenges","volume":"248","author":"Cui","year":"2023","journal-title":"Pathol Res Pract"},{"key":"key20260206094801_b74-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"1399868","DOI":"10.3389\/fonc.2024.1399868","article-title":"A case of surgically treated non-metastatic SMARCA4-deficient undifferentiated thoracic tumor: A case report and literature review","volume":"14","author":"Yin","year":"2024","journal-title":"Front Oncol"},{"key":"key20260206094801_b75-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1158\/1078-0432.CCR-15-1468","article-title":"SMARCA4\/BRG1 is a novel prognostic biomarker predictive of cisplatin-based chemotherapy outcomes in resected non-small cell lung cancer","volume":"22","author":"Bell","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key20260206094801_b76-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jtho.2020.01.002","article-title":"Clinicopathologic characteristics of BRG1-deficient NSCLC","volume":"15","author":"Dagogo-Jack","year":"2020","journal-title":"J Thorac Oncol"},{"key":"key20260206094801_b77-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/1759-7714.13070","article-title":"Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: A case report","volume":"10","author":"Naito","year":"2019","journal-title":"Thorac Cancer"},{"key":"key20260206094801_b78-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1158\/2159-8290.CD-18-0099","article-title":"STK11\/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma","volume":"8","author":"Skoulidis","year":"2018","journal-title":"Cancer Discov"},{"key":"key20260206094801_b79-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1042\/BST20150048","article-title":"Dysregulation of the keap1-Nrf2 pathway in cancer","volume":"43","author":"Leinonen","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"key20260206094801_b80-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejca.2018.02.021","article-title":"Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy","volume":"94","author":"Gatalica","year":"2018","journal-title":"Eur J Cancer"},{"key":"key20260206094801_b81-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1158\/2159-8290.CD-21-0248","article-title":"Smarca4 inactivation promotes lineage-specific transformation and early metastatic features in the lung","volume":"12","author":"Concepcion","year":"2022","journal-title":"Cancer Discov"},{"key":"key20260206094801_b82-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1002\/ctm2.167","article-title":"Hyperprogression: A novel response pattern under immunotherapy","volume":"10","author":"Han","year":"2020","journal-title":"Clin Transl Med"},{"key":"key20260206094801_b83-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1177\/10668969241296128","article-title":"SMARCA4 deficient gastric carcinoma with squamous differentiation in a young patient with aggressive clinical course","volume":"33","author":"Misra","year":"2025","journal-title":"Int J Surg Pathol"},{"key":"key20260206094801_b84-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1177\/00031348221146972","article-title":"Identification and treatment of SMARCA4 deficient poorly differentiated gastric carcinoma","volume":"89","author":"Bhat","year":"2023","journal-title":"Am Surg"},{"key":"key20260206094801_b85-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/path.6064","article-title":"Ovarian high-grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance","volume":"260","author":"Kido","year":"2023","journal-title":"J Pathol"},{"key":"key20260206094801_b86-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15212\/bioi-2024-0066","article-title":"Integrated network ethnopharmacology, molecular docking, and ADMET analysis strategy for exploring the anti-breast cancer activity of ayurvedic botanicals targeting the progesterone receptor","volume":"5","author":"Mokashi","year":"2024","journal-title":"BIO Integr"},{"key":"key20260206094801_b87-ol-31-2-15405","first-page":"0080","article-title":"Intermittent F-actin perturbations by magnetic fields inhibit breast cancer metastasis","volume":"6","author":"Ji","year":"2023","journal-title":"Research (Wash DC)"},{"key":"key20260206094801_b88-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5847\/wjem.j.1920-8642.2022.015","article-title":"Protective effect of mesenchymal stem cell-derived exosomal treatment of hippocampal neurons against oxygen-glucose deprivation\/reperfusion-induced injury","volume":"13","author":"Guo","year":"2022","journal-title":"World J Emerg Med"},{"key":"key20260206094801_b89-ol-31-2-15405","doi-asserted-by":"publisher","first-page":"114697","DOI":"10.1016\/j.celrep.2024.114697","article-title":"Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironment","volume":"43","author":"Luo","year":"2024","journal-title":"Cell Rep"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T07:48:09Z","timestamp":1770364089000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":89,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11,26]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15405","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]}}}